IDweek2023 | PRO: The Imperative of Dilated Retinal Exams in All Pediatric Patients with Candidemia

IDweek2023 | PRO: The Imperative of Dilated Retinal Exams in All Pediatric Patients with Candidemia

2023.10.26
IDweek 2023 PRO: The Imperative of Dilated Retinal Exams in All Pediatric Patients with Candidemia Candidemia, a systemic fungal infection caused by Candida species, poses a substantial threat to pediatric patients. While the management of candidemia primarily revolves around the administration of appropriate antifungal therapy, the necessity of ophthalmologic evaluation, specifically dilated retinal exams, continues to be a subject of debate. In this comprehensive article, we advocate for the routine use of dilated retinal exams in all pediatric patients with candidemia, emphasizing the numerous potential benefits and addressing the concerns and complexities surrounding this practice.
IDweek2023 | Reevaluating the Necessity of Lumbar Punctures in Neonatal Gram-Negative Meningitis

IDweek2023 | Reevaluating the Necessity of Lumbar Punctures in Neonatal Gram-Negative Meningitis

2023.10.26
IDweek 2023 Reevaluating the Necessity of Lumbar Punctures in Neonatal Gram-Negative Meningitis Neonatal gram-negative meningitis is a devastating and potentially life-threatening infection that poses significant challenges to clinicians. The management of this condition typically involves prolonged antibiotic therapy, with the duration often determined by the results of lumbar punctures (LPs). However, recent discussions have raised important questions about the necessity of LPs in determining the end of therapy for neonatal gram-negative meningitis. In this article, we will delve into the arguments presented by Dr. Karen M. Puopolo, exploring the potential benefits and drawbacks of LPs in this context, and consider the broader implications of her work.
IDweek202 | The Importance of Performing Lumbar Puncture to Determine the End of Therapy in Neonatal Gram-negative Meningitis: Insights from Mano a Mano

IDweek202 | The Importance of Performing Lumbar Puncture to Determine the End of Therapy in Neonatal Gram-negative Meningitis: Insights from Mano a Mano

2023.10.26
IDweek2023 The Importance of Performing Lumbar Puncture to Determine the End of Therapy in Neonatal Gram-negative Meningitis: Insights from Mano a Mano Neonatal gram-negative meningitis is a devastating infection that can lead to significant morbidity and mortality. The appropriate duration of antimicrobial therapy for this condition has been a topic of debate among experts in the field. In the Mano a Mano conference, Dr. Pablo J. Sanchez presented compelling evidence supporting the performance of lumbar puncture to determine the end of therapy in neonatal gram-negative meningitis. This article will delve into the key points presented by Dr. Sanchez, highlighting the importance of this diagnostic procedure in guiding treatment decisions and further exploring the nuances of neonatal gram-negative meningitis management.
IDweek2023 | Treatment Approach for Neonates with Bacteremic UTI: IV Therapy Only

IDweek2023 | Treatment Approach for Neonates with Bacteremic UTI: IV Therapy Only

2023.10.26
IDweek 2023 Treatment Approach for Neonates with Bacteremic UTI: IV Therapy Only Neonatal bacteremic urinary tract infection (UTI) is a life-threatening condition that demands immediate and effective treatment to safeguard the health and well-being of the affected infants. A crucial debate in the management of these cases revolves around the choice of treatment, specifically whether neonates with bacteremic UTI should be exclusively treated with intravenous (IV) therapy or if alternative treatment approaches, potentially involving oral therapy, can be considered. This article delves deeper into the arguments and evidence surrounding the use of IV therapy as the primary treatment modality for neonates with bacteremic UTI.
IDweek2023 | Optimizing Neonatal UTI Management: Weighing IV and Oral Therapies

IDweek2023 | Optimizing Neonatal UTI Management: Weighing IV and Oral Therapies

2023.10.26
IDweek 2023 Optimizing Neonatal UTI Management: Weighing IV and Oral Therapies Neonatal urinary tract infections (UTIs) present a significant challenge in pediatric infectious diseases, with an ongoing debate among healthcare professionals about the best approach for managing neonates with bacteremic UTIs. This article provides a comprehensive examination of the key considerations when it comes to neonatal UTI treatment, focusing on the pros and cons of intravenous (IV) and oral therapy options.
IDweek2023 | Navigating the Future of Healthcare: A Comprehensive Exploration of the Intersection of Artificial Intelligence and Medicine

IDweek2023 | Navigating the Future of Healthcare: A Comprehensive Exploration of the Intersection of Artificial Intelligence and Medicine

2023.10.26
IDweek2023 Navigating the Future of Healthcare: A Comprehensive Exploration of the Intersection of Artificial Intelligence and Medicine The world stands on the precipice of a technological revolution as the advent of Artificial Intelligence (AI) ushers in a new era of possibilities across various sectors. One of the most significant beneficiaries of this revolution is healthcare, a sector that is ripe for transformative change. The potential of AI to revolutionize healthcare is not just a promising proposition, but an unfolding reality. However, the path to fully integrating AI into healthcare is not without challenges. It is crucial to navigate these hurdles carefully as we move towards a future where AI and healthcare work in harmony to enhance the health outcomes of individuals and communities at large.
Doctor Philippa Easterbrook: WHO to Release New Hepatitis B Guidelines, Focusing on Expanding Treatment Eligibility and Simplifying Diagnosis and Treatment Pathways

Doctor Philippa Easterbrook: WHO to Release New Hepatitis B Guidelines, Focusing on Expanding Treatment Eligibility and Simplifying Diagnosis and Treatment Pathways

2023.10.24
At the 58th European Association for the Study of the Liver (EASL) Annual Meeting (EASL 2023) and EASL Congress 2023, Doctor Philippa Easterbrook, Senior Scientist at the Global Hepatitis Programme of the Department of HIV at the World Health Organization (WHO) headquarters in Geneva, attended the WHO-ECDC Joint Forum. She discussed the new directions being drafted in WHO's updated Hepatitis B guidelines, focusing on expanding simplified treatment criteria, service delivery, and innovative diagnostics. Hepatology Digest had the privilege to interview Doctor Philippa Easterbrook about WHO's 2030 goals, the progress of the new Hepatitis B guidelines, essential information, and the global challenges and opportunities in addressing Hepatitis B prevention and control.
EASL Secretary-General: Doctor Thomas Berg Discusses Highlights of the Conference, NAFLD Renaming, and Future Directions for Fatty Liver and Hepatitis B Research

EASL Secretary-General: Doctor Thomas Berg Discusses Highlights of the Conference, NAFLD Renaming, and Future Directions for Fatty Liver and Hepatitis B Research

2023.10.24
The 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and the EASL Congress 2023 have brought forth a splendid academic gathering for the global hepatology community. The Hepatology Digest reporting team had the privilege of interviewing Doctor Thomas Berg, EASL Secretary-General and Head of the Hepatology Department at Leipzig University Hospital. He shared with us the highlights of this conference, his perspective on significant research developments, thoughts on the renaming of Non-Alcoholic Fatty Liver Disease (NAFLD), and insights into the future research directions for fatty liver and hepatitis B.
APASL President Doctor Shuichiro Shiina Invites You to Attend the 2024 the Asian Pacific Association for the Study of the Liver Conference in Kyoto, Japan

APASL President Doctor Shuichiro Shiina Invites You to Attend the 2024 the Asian Pacific Association for the Study of the Liver Conference in Kyoto, Japan

2023.10.24
At the 58th European Association for the Study of the Liver (EASL) Annual Meeting, also known as EASL 2023 Congress, Professor Shuichiro Shiina, the President of the Asian Pacific Association for the Study of the Liver (APASL)  and a professor of gastroenterology at Juntendo University in Japan, was invited to attend the conference. He engaged in a stimulating roundtable discussion with hepatologists from various countries on the topic of "Hepatology and Hepatologists of the Future: Opportunities and Challenges." Hepatology Digest had the privilege of inviting Doctor Shuichiro Shiina to share his insights and experiences from his visit to EASL, as well as his expectations for the 2024 APASL Annual Meeting.